GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (HKSE:06929) » Definitions » PB Ratio

OrbusNeich Medical Group Holdings (HKSE:06929) PB Ratio : 1.24 (As of Dec. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is OrbusNeich Medical Group Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-12), OrbusNeich Medical Group Holdings's share price is HK$4.36. OrbusNeich Medical Group Holdings's Book Value per Share for the quarter that ended in Jun. 2024 was HK$3.53. Hence, OrbusNeich Medical Group Holdings's PB Ratio of today is 1.24.

The historical rank and industry rank for OrbusNeich Medical Group Holdings's PB Ratio or its related term are showing as below:

HKSE:06929' s PB Ratio Range Over the Past 10 Years
Min: 0.9   Med: 1.99   Max: 4.29
Current: 1.24

During the past 5 years, OrbusNeich Medical Group Holdings's highest PB Ratio was 4.29. The lowest was 0.90. And the median was 1.99.

HKSE:06929's PB Ratio is ranked better than
73.19% of 787 companies
in the Medical Devices & Instruments industry
Industry Median: 2.34 vs HKSE:06929: 1.24

During the past 12 months, OrbusNeich Medical Group Holdings's average Book Value Per Share Growth Rate was 7.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 119.90% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of OrbusNeich Medical Group Holdings was 119.90% per year. The lowest was 119.90% per year. And the median was 119.90% per year.

Back to Basics: PB Ratio


OrbusNeich Medical Group Holdings PB Ratio Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings PB Ratio Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
- - - 2.90 2.03

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only - 2.90 2.65 2.03 1.20

Competitive Comparison of OrbusNeich Medical Group Holdings's PB Ratio

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's PB Ratio falls into.



OrbusNeich Medical Group Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

OrbusNeich Medical Group Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=4.36/3.526
=1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


OrbusNeich Medical Group Holdings  (HKSE:06929) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


OrbusNeich Medical Group Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OrbusNeich Medical Group Holdings Business Description

Traded in Other Exchanges
Address
3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich is a China-based global medical device maker of endovascular interventional instruments with global reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's largest revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its largest product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.
Executives
Harmony Tree Limited 2101 Beneficial owner
Shenzhen Capital Group Co., Ltd. 2201 Interest of corporation controlled by you
Suzhou Red Earth Yeju Investment Ltd. 2101 Beneficial owner
Chien David 2201 Interest of corporation controlled by you
Lau Kwai Ching Denise 2201 Interest of corporation controlled by you
Shen Chuang Tou Zhi Zao Ye Zhuan Xing Sheng Ji Xin Cai Liao Ji Jin You Xian He Huo 2201 Interest of corporation controlled by you
Shen Chuang Tou Hong Tu Si Mu Gu Quan Tou Zi Ji Jin Guan Li Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Hong Tu Ye Ju Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you

OrbusNeich Medical Group Holdings Headlines

No Headlines